Bortezomib and lenalidomide for multiple myeloma patients relapsed after allogeneic stem cell transplantation

被引：0
|
作者：
Corradini, P. [1 ]
Montefusco, V. [1 ]
Bruno, B. [2 ]
Merla, E. [3 ]
Sorasio, R. [2 ]
Olivieri, A. [4 ]
Falcone, A. [3 ]
Giaccone, L. [2 ]
Farina, L. [1 ]
Spina, F. [1 ]
Dodero, A. [1 ]
Milani, R. [1 ]
Carella, A. M. [3 ]
Cascavilla, N. [3 ]
机构：
[1] Ist Nazl Tumori, I-20133 Milan, IT, Italy
[2] Osped Giovanni Battista, Turin, IT, Italy
[3] Casa Sollievo Sofferenza Hosp, San Giovanni Rotondo, IT, Italy
[4] Osped San Carlo Borromeo Milano, Potenza, IT, Italy
来源：
BONE MARROW TRANSPLANTATION | 2009年 / 43卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S148 / S148
页数：1
相关论文
共 50 条
  • [1] Lenalidomide after allogeneic stem cell transplantation in multiple myeloma
    Lehmann, Friederike
    Jean, El-Cheikh
    Zabelina, Tatjana
    Ayuk, Francis
    Wolschke, Christine
    Petersen, Lars
    Bacher, Ulrike
    Zander, Axel R.
    Blaise, Didier
    Mohty, Mohamad
    Nikolaus, Kroeger
    BLOOD, 2007, 110 (11) : 284B - 285B
  • [2] Lenalidomide after allogeneic stem cell transplantation in multiple myeloma
    Lehmann, F.
    El-Cheikh, J.
    Zabelina, T.
    Ayuk, F.
    Wolschke, C.
    Petersen, L.
    Bacher, U.
    Zander, A. R.
    Blaise, D.
    Mohty, M.
    Kroeger, N.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S182 - S183
  • [3] Immunomodulatory effects of bortezomib/lenalidomide combination therapy as maintenance early after allogeneic stem cell transplantation for patients with multiple myeloma
    Stuebig, T.
    Wolschke, C.
    Heinzelmann, M.
    Badbaran, A.
    Ayuk, F.
    Bernhard, F.
    Kroeger, N.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S329 - S329
  • [4] Lenalidomide as Salvage Therapy after Allogeneic Stem Cell Transplantation in Multiple Myeloma
    Lehmann, Friederike
    El-Cheilch, Jean, Jr.
    Zabelina, Tatjana
    Ayuk, Francis
    Wolschke, Christine
    Atanackovic, Djordje
    Bacher, Ulrike
    Zander, Axel R.
    Blaisel, Didier
    Mohty, Mohamad
    Kroeger, Nicolaus
    BLOOD, 2008, 112 (11) : 1269 - 1269
  • [5] COMPARISON OF BORTEZOMIB AND LENALIDOMIDE BASED REGIMENS AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA PATIENTS
    Malkan, U.
    Gunes, G.
    Yayar, O.
    Can, E. Saribacak
    Okay, M.
    Goker, H.
    LEUKEMIA RESEARCH, 2017, 61 : S22 - S23
  • [6] Successful salvage therapy using lenalidomide in a patient with relapsed multiple myeloma after allogeneic hematopoietic stem cell transplantation
    Suzuki, Tomotaka
    Kusumoto, Shigeru
    Yoshida, Tatsuya
    Mori, Fumiko
    Ito, Asahi
    Ri, Masaki
    Ishida, Takashi
    Komatsu, Hirokazu
    Niimi, Akio
    Iida, Shinsuke
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 97 (04) : 540 - 543
  • [7] Successful salvage therapy using lenalidomide in a patient with relapsed multiple myeloma after allogeneic hematopoietic stem cell transplantation
    Tomotaka Suzuki
    Shigeru Kusumoto
    Tatsuya Yoshida
    Fumiko Mori
    Asahi Ito
    Masaki Ri
    Takashi Ishida
    Hirokazu Komatsu
    Akio Niimi
    Shinsuke Iida
    International Journal of Hematology, 2013, 97 : 540 - 543
  • [8] Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma
    Baertsch, Marc-Andrea
    Mai, Elias K.
    Hielscher, Thomas
    Bertsch, Uta
    Salwender, Hans J.
    Munder, Markus
    Fuhrmann, Stephan
    Duehrsen, Ulrich
    Brossart, Peter
    Neben, Kai
    Schlenzka, Jana
    Kunz, Christina
    Raab, Marc S.
    Hillengass, Jens
    Jauch, Anna
    Seckinger, Anja
    Hose, Dirk
    Luntz, Steffen
    Sonneveld, Pieter
    Lokhorst, Henk
    Martin, Hans
    Goerner, Martin
    Hoffmann, Martin
    Lindemann, Hans-Walter
    Bernhard, Helga
    Blau, Igor W.
    Scheid, Christof
    Besemer, Britta
    Weisel, Katja C.
    Haenel, Mathias
    Duerig, Jan
    Goldschmidt, Hartmut
    BLOOD CANCER JOURNAL, 2021, 11 (01)
  • [9] Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma
    Marc-Andrea Baertsch
    Elias K. Mai
    Thomas Hielscher
    Uta Bertsch
    Hans J. Salwender
    Markus Munder
    Stephan Fuhrmann
    Ulrich Dührsen
    Peter Brossart
    Kai Neben
    Jana Schlenzka
    Christina Kunz
    Marc S. Raab
    Jens Hillengaß
    Anna Jauch
    Anja Seckinger
    Dirk Hose
    Steffen Luntz
    Pieter Sonneveld
    Henk Lokhorst
    Hans Martin
    Martin Goerner
    Martin Hoffmann
    Hans-Walter Lindemann
    Helga Bernhard
    Igor W. Blau
    Christof Scheid
    Britta Besemer
    Katja C. Weisel
    Mathias Hänel
    Jan Dürig
    Hartmut Goldschmidt
    Blood Cancer Journal, 11
  • [10] Daratumumab as salvage therapy in relapsed/refractory multiple myeloma patients after allogeneic stem cell transplantation
    Essmann, S.
    von Pein, U. -M.
    Klyuchnikov, E.
    Janson, D.
    Bonmann, S.
    Ayuk, F. A.
    Wolschke, C.
    Kroeger, N.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 190 - 190
12345